149 related articles for article (PubMed ID: 1183243)
1. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
Segal E; Romano A; Eylan E; Stein R
Chemotherapy; 1975; 21(6):358-66. PubMed ID: 1183243
[TBL] [Abstract][Full Text] [Related]
2. Experimental and clinical studies of 5-fluorocytosine activity in candida ocular infections, II. The effect of 5-fluorocytosine in treating experimental candida infection in rabbits' eyes.
Segal E; Romano A; Eylan E; Stein R
Infection; 1975; 3(3):165-8. PubMed ID: 1223007
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity of Candida spp. to 5-fluorocytosine, amphotericin B and imidazoles. Antifongiogram of 120 strains isolated at the Vaudois University Hospital Center during the autumn-winter seasons of 1978 and 1980].
Sakellarides E
Schweiz Med Wochenschr; 1981 Sep; 111(37):1367-72. PubMed ID: 7291960
[TBL] [Abstract][Full Text] [Related]
4. Treatment of external ocular Candida infections with 5-fluorocytosine.
Romano A; Segal E; Eylan E; Stein R
Ophthalmologica; 1976; 172(4):282-6. PubMed ID: 765917
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
Nobre G; Sobral T; Ferreira AF
Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of 5-fluorocytosine against Candida and Torulopsis species.
Shadomy S; Kirchoff CB; Ingroff AE
Antimicrob Agents Chemother; 1973 Jan; 3(1):9-14. PubMed ID: 4799552
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
8. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
[TBL] [Abstract][Full Text] [Related]
9. Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity.
Edwards JE; Montgomerie JZ; Ishida K; Morrison JO; Guze LB
J Infect Dis; 1977 Feb; 135(2):294-7. PubMed ID: 320277
[TBL] [Abstract][Full Text] [Related]
10. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
Costa AL; Valenti A; Costa G; Calogero F
G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
[TBL] [Abstract][Full Text] [Related]
11. [The resistance behavior of yeast isolates from defined patient groups to 5-fluorocytosine].
Weber S; Polak-Wyss A
Mycoses; 1991; 34 Suppl 1():77-81. PubMed ID: 1818269
[TBL] [Abstract][Full Text] [Related]
12. 5-Fluorocytosine resistance in candida spp. and Torulopsis glabrata.
Schönebeck J; Anséhn S
Sabouraudia; 1973 Mar; 11(1):10-20. PubMed ID: 4574129
[No Abstract] [Full Text] [Related]
13. A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine.
Auger P; Dumas C; Joly J
J Infect Dis; 1979 May; 139(5):590-4. PubMed ID: 374653
[TBL] [Abstract][Full Text] [Related]
14. Synergism of amphotericin B and 5-fluorocytosine for candida species.
Montgomerie JZ; Edwards JE; Guze LB
J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
[TBL] [Abstract][Full Text] [Related]
15. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
Karlowsky JA; Hoban DJ; Zhanel GG; Goldstein BP
Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
[TBL] [Abstract][Full Text] [Related]
16. [Sensitivity and resistance of pathogenic yeasts to 5-fluoropyrimidines. I.--Relation between the phenotypes of resistance to 5-fluorocytosine, the serotype of Candida albicans and the ecology of various species of Candida of human origin (author's transl)].
Drouhet E; Mercier-Soucy L; Montplaisir S
Ann Microbiol (Paris); 1975; 126B(1):25-39. PubMed ID: 1108732
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of yeast isolates from defined German patient groups to 5-fluorocytosine.
Weber S; Polak A
Mycoses; 1992; 35(7-8):163-71. PubMed ID: 1287480
[TBL] [Abstract][Full Text] [Related]
18. Identification and antifungal susceptibility of Candida isolated from intensive care unit patients.
Zer Y; Balci I; Meriç G
New Microbiol; 2002 Oct; 25(4):489-94. PubMed ID: 12437230
[TBL] [Abstract][Full Text] [Related]
19. The antimycotic activity of 5-fluorocytosine.
Holt RJ; Newman RL
J Clin Pathol; 1973 Mar; 26(3):167-74. PubMed ID: 4700499
[TBL] [Abstract][Full Text] [Related]
20. Experimental endocarditis: prophylaxis of Candida albicans infections by 5-fluorocytosine in rabbits.
Demierre G; Freedman LR
Antimicrob Agents Chemother; 1979 Sep; 16(3):252-4. PubMed ID: 389156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
